Skip to main content

SURI

Simplify Propel Opportunities ETF

Spotlight Banner
as of 09/20/2023

NAV

$ 21.30

NAV Change

- $ 0.16 /0.75%

Price

$ 21.32

Price Change

- $ 0.11 /0.51%
The Simplify Propel Opportunities ETF (SURI) seeks to provide long-term growth of capital by providing investors with exposure to biotech, pharma, health care technology, and life science companies that are believed to be overlooked by investors, thereby presenting significant opportunities for capital appreciation.

The fund is sub-advised by Propel, which uses its deep scientific and commercial expertise in health sciences to identify the most promising health science investment opportunities.

Fund Overview

As of 09/20/2023

Ticker Symbol
SURI
Gross Expense Ratio
2.76%
Net Expense Ratio
2.51%
CUSIP
82889N624
Total Assets
$100,532,532.32
Shares Outstanding
4,720,001
Distribution Yield as of 06/30/2023 Distribution yield calculation employs the most recent distribution, and multiplies the payment by 12 (monthly) or 4 (quarterly) to get an annualized total. The annualized total is then divided by the most recent net asset value (NAV) to determine the distribution yield.
Distribution Yield Close
Distribution yield calculation employs the most recent distribution, and multiplies the payment by 12 (monthly) or 4 (quarterly) to get an annualized total. The annualized total is then divided by the most recent net asset value (NAV) to determine the distribution yield.
12.41%
Distribution Frequency
Quarterly
SEC 30-Day Yield as of 08/31/2023 SEC 30-day Yield is available once fund has a full quarter of performance.
SEC 30-Day Yield Close
SEC 30-day Yield is available once fund has a full quarter of performance.
0.78%
Unsubsidized 30-Day SEC Yield as of 08/31/2023
0.54%
Options Available
No
Inception Date
02/07/2023
Premium/Discount (%) as of 09/20/2023
0.10%
NAV Per Share as of 09/20/2023
$21.30
Market Price as of 09/20/2023
$21.32
30-Day Median Bid-Ask Spread
0.80%
Bid/Ask
$21.16/$21.74
Midpoint Price
$21.45
Volume
26
NAV Symbol
SURI.NV
IOPV Symbol
SURI.IV
Shares Out. Symbol
SURI.SO
Schedule K-1
No

Management Fees

This table describes the fees and expenses that you may pay if you buy, sell, and hold shares of the Fund. Investors purchasing or selling shares of the Fund in the secondary market may be subject to costs (including customary brokerage commissions) charged by their broker. The fee table located in the prospectus and updates in prospectus supplements prevail.

Annual Fund Operating Expenses (expenses that you pay each year as a percentage of the value of your investment)
Management Fees1 2.75%
Distribution and Service (12b-1) Fees 0.00%
Other Expenses2 0.00%
Acquired Fund Fees and Expenses3 0.01%
Total Annual Fund Operating Expenses 2.76%
Fee Waiver4 (0.25)%
Total Annual Fund Operating Expenses After Fee Waiver 2.51%
1. Estimated for the Fund’s initial fiscal year. The Fund has agreed to pay the adviser as compensation under a management agreement a monthly advisory fee (as a percentage of daily net assets) computed at the annual rate of 2.75% on assets up to $1 billion; 2.50% on assets over $1 billion and less than $5 billion; 2.00% on assets over $5 billion and less than $10 billion; and 1.00% on assets over $10 billion.

2. Other Expenses are estimated for the Fund’s initial fiscal year.

3. Acquired Fund Fees and Expenses, are estimated for the Fund’s initial fiscal year, are the indirect costs of investing in other investment companies. The operating expenses in this fee table will not correlate to the expense ratio in the Fund’s financial highlights located in the prospectus because the financial statements include only the direct operating expenses incurred by the Fund.

4. The adviser and sub-adviser have collectively agreed to waive 0.25% of the management and subadvisory fee on an annualized basis through December 31, 2023. This waiver may be terminated by the Fund's Board of Trustees on 60 days' notice and terminates automatically if the management agreement or sub-advisory agreement is terminated.

Fund Performance

As of 08/31/2023 06/30/2023

Cumulative 1 Month 3 Month 6 Month YTD 1 Year Since Inception
NAV -3.03% 3.83% -2.74% -7.09%
Market Price -2.49% 4.12% -2.28% -5.37%
Annualized 1 Year 3 Year Since Inception
NAV
Market Price
Cumulative 1 Year Since Inception
NAV -4.97%
Market Price -3.57%
Annualized 1 Year 3 Year 5 Year Since Inception
NAV
Market Price

Historical Premium/Discount

Calendar Year 2022 2nd Quarter of 2023
Days Traded at Premium
N/A
30
Days Traded at Discount
N/A
32
Ticker Name Quantity Weight
TELSAT Telesat Canada / Telesat LLC 2000000 1.43%
TELSAT TELESAT CANADA/TELESAT L 6.5 10/15/2027 3124000 1.73%
BSV VANGUARD SHORT-TERM BOND ETF 27712 2.07%
FLOT ISHARES TR FLOATING RATE BD ETF 31437 1.59%
FLRN SPDR Bloomberg Barclays Investment Grade Floating Rate ETF 75068 2.29%
IBDO IBDO 83187 2.10%
IBDP IBDP 85442 2.10%
ICSH ICSH 41833 2.09%
KYN KAYNE ANDE COM STK USD0.001 147033 1.28%
LQD ISHARES IBOXX INV GR CORP BD 19505 2.02%
MBB ISHARES BARCLAYS MBS BOND FD 22400 2.01%
PAA Plains All American Pipeline L 113500 1.76%
SLQD iShares 0-5 Year Investment Grade Corporate Bond ETF 43571 2.08%
SPSB SPDR SERIE LEHMAN SHRT TRM CORPOR E 71380 2.08%
VMBS VANGUARD S VANGUARD MTG-BACKED SECS 45528 2.02%
- CHINOOK THERAPEUTICS INC CVR 25000 0.01%
ADAP ADAPTIMMUNE THERAPEUTICS-ADR 150000 0.11%
AGIO AGIOS PHARMACEUTICALS INC USD 0.001 5792 0.14%
AKRO Akero Therapeutics Inc 59777 2.89%
ALLO Allogene Therapeutics Inc 245000 0.92%
ANNX ANNEXON INC 492595 1.28%
APLT APPLIED THERAPEUTICS INC 2417505 6.42%
ATAI ATAI LIFE SCIENCES NV 140000 0.19%
ATHA ATHIRA PHARMA INC USD 0.0001 1492792 3.04%
CRNX Crinetics Pharmaceuticals Inc 115000 3.27%
CYBN CYBIN INC 500000 0.21%
DAWN DAY ONE BIOPHARMACEUTICALS I 175018 2.29%
EIGR EIGER BIOPHARMACEUTICALS INC 2700000 1.02%
FULC Fulcrum Therapeutics Inc 465000 2.05%
HRTX HERON THERAPEUTICS INC USD 0.01 431590 0.49%
KURA Kura Oncology Inc 80000 0.72%
KYMR KYMERA THERAPEUTICS INC 30515 0.53%
MCRB SERES THERAPEUTICS INC USD 0.001 550626 1.46%
MDGL Madrigal Pharmaceuticals Inc 14294 2.30%
MIRM Mirum Pharmaceuticals Inc 70000 2.16%
MRNS MARINUS PHARMACEUTICALS INC NPV 150000 1.07%
PAGP Plains GP Holdings LP 1372360 22.28%
PHAT Phathom Pharmaceuticals Inc 237935 2.57%
REPL Replimune Group Inc 150000 2.48%
RNA AVIDITY BIOSCIENCES INC 125000 0.88%
SAGE SAGE THERAPEUTICS INC USD 0.0001 120030 2.38%
STOK Stoke Therapeutics Inc 102985 0.45%
STRO Sutro Biopharma Inc 120000 0.42%
TCRX TCRX 1046916 2.96%
TSAT Telesat Corp 260781 4.00%
XFOR XFOR 400000 0.41%
- Estimated Cash -59223 -0.06%

Recent Distributions

Ex-Dividend Date Record Date Payable Date Ordinary Income Short Term Capital Gains Long Term Capital Gains Return of Capital Total Distribution
$0.68000 $0.00000 $0.00000 $0.00000 $0.68000
$1.00000 $0.00000 $0.00000 $0.00000 $1.00000
View Distribution History

Register for Simplify's Investor Hub

  • In-depth case studies provide valuable insights into practical portfolio problems and their solutions
  • Simplify curated model portfolios that show investors how to incorporate alternatives into their portfolio
  • Stay up-to-date with our latest thoughts on markets via our weekly market commentaries
Create Your Account
Register Info
Contact Us